Current Pharmaceutical Biotechnology

Volume 2, Number 4, December 2001

Links for this Journal

Book Reviews

Editorial
pp. i-ii(2)
Authors: Grillo-Lopez A.J.; McClure A.; Dallaire B.K.

Links for this article

Reviews

Non-Hodgkin's Lymphoma: Review of Conventional Treatments
pp. 279-291(14)
Authors: Multani P.; White C.A.; Grillo-Lopez A.

Links for this article

The History and Rationale for Monoclonal Antibodies in the Treatment of Hematologic Malignancy
pp. 293-300(7)
Author: Dillman R.O.

Links for this article

Monoclonal Antibodies: A New Era in the Treatment of Non-Hodgkin's Lymphoma
pp. 301-311(12)
Authors: Grillo-Lopez A.J.; Dallaire B.K.; McClure A.; Weaver R.; Varns C.; Wei A.; Allen R.; Lee D.; Shen D.; Leonard J.; Multani P.; White C.A.

Links for this article

Toxin-Labeled Monoclonal Antibodies
pp. 313-325(14)
Author: Kreitman R.J.

Links for this article

Radioimmunotherapy of B-Cell NHL
pp. 327-339(14)
Authors: Meredith R.F.; Knox S.J.

Links for this article

Zevalin TM: 90 Yttrium Labeled Anti-CD20 (Ibritumomab Tiuxetan), a New Treatment for Non-Hodgkin's Lymphoma
pp. 341-349(10)
Authors: Krasner C.; Joyce R.M.

Links for this article

Monoclonal Antibodies in the Treatment of Hematologic Malignancies: Radiation Dosimetry Aspects
pp. 351-356(6)
Authors: Stabin M.G.; Brill A.B.

Links for this article

Antibody Therapy of Acute and Chronic Leukemias
pp. 357-367(11)
Authors: Cataland S.R.; Lucas M.; Byrd J.C.

Links for this article

Future Approaches for Treating Hematologic Disease
pp. 369-382(14)
Authors: Reff M.; Braslawsky G.; Hanna N.

Links for this article